Study Trip definition

Study Trip means the journey taken by the Insured Person to and from the Country/Region of Overseas Study for the purpose of studying abroad at the Overseas Educational Institution, which shall commence when the Insured Person completes the immigration departure clearance procedure in Hong Kong on or after the commencement date of the Period of Insurance specified in the Policy Schedule for the purpose of commencing such trip to the Country/Region of Overseas Study and ends (a) on the last day of the Period of Insurance specified in the Policy Schedule or (b) when the Insured Person completes the immigration arrival clearanceprocedure for returning to Hong Kong, whichever is earlier and covers all ancillary trips to other countries/regions for leisure travel during the aforesaid period.
Sample 1Sample 2Sample 3
Study Trip means a journey undertaken by the Insured Person outside Hong Kong for the purpose of furthering his/her study at the Overseas Educational Institution and which shall be deemed to commence from the date the Insured Person departs from Hong Kong to travel to the Overseas Educational Institution and shall be deemed to cease on the date the Insured Person returns permanently to Hong Kong after completion or interruption of his/her education at the Overseas Educational Institution. Any leisure trip (except in Hong Kong) taken by the Insured Person during such Study Trip shall also be covered.
Sample 1Sample 2

Examples of Study Trip in a sentence

  • Study Trip to Narora Nuclear Power Plant In association with the Nuclear Power Corporation of India Ltd.

  • TU Delft Intercontinental Study Trip Program, Delft University of Technology, Visit to LSU.

  • If during the Period of Insurance the Insured returns to Hong Kong for temporary stay during the course of the Covered Study Trip, and sustains Accidental Bodily Injury or suffers from Sickness requiring Confinement in Hospital as a Resident In-patient, the Company shall pay for Medical Expenses incurred as such subject to a maximum of HK$50,000 per Period of Insurance.

  • The Company shall pay the Indemnity for damages which the Insured becomes legally liable to pay because of Accidental Bodily Injury to any other person or destruction of property of others caused by an Accident occurred in the course of a Covered Study Trip during the Period of Insurance.

  • Personal Property means personal belongings of the Insured or for which he/she is responsible which are taken by him/her on Covered Study Trip or acquired during the Covered Study Trip.

  • Proposals for travel study trips will be submitted on the "Request for Travel Study Trip" form.

  • If during the Period of Insurance the Insured dies during the course of the Covered Study Trip as a result of Accidental Bodily Injury or Sickness, the Company shall pay for the Transfer Expenses incurred for the Transfer of the mortal remains from place of death to Hong Kong, or the cost of local burial at the place of death up to one hundred percent (100%) of the Amount of Benefit for Return of Mortal Remains stated in the Policy Schedule.

  • The Company also covers the Medical Expenses for dental treatment as a result of an Accidental Bodily Injury to sound and natural teeth, and dental treatment for the relief of sudden and acute pain suffered by the Insured during the Covered Study Trip, provided such dental treatment is considered Medically Necessary and certified by a Physician.

  • If during the Period of Insurance the Insured sustains an Accidental Bodily Injury during the course of the Covered Study Trip, which directly results in loss of life of the Insured within thirty hundred sixty-five (365) days from the date of Accident, the Company shall pay one hundred percent (100%) of the Amount of Benefit for Personal Accident stated in the Policy Schedule less any amount paid for Accidental Disability arising from the same or different Accidental Bodily Injury.

  • If during the Period of Insurance the Insured suffers Accidental loss of or damage to the Insured’s baggage and Personal Property contained in such baggage which occurs outside of Hong Kong during the course of the Covered Study Trip, the Company shall reimburse up to one hundred percent (100%) of the Amount of Benefit for Personal Baggage stated in the Policy Schedule per Period of Insurance.

Related to Study Trip

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, or Pivotal Study, as applicable; but excluding any Post-Approval Studies.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase 3 Study means a clinical study of a drug candidate in human patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Regulatory Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable clinical study prescribed by the relevant Regulatory Authority in a country other than the United States. The relevant drug candidate may be administered to patients as a single agent or in combination with other investigational or marketed agents.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase 1 Trial means, with respect to a Licensed Product, a clinical trial (or — in case of a multi-phase clinical trial — those parts of a clinical trial) in line with the provisions of 21CFR312, Section 21 (a).

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).

  • Development Phase means the period before a vehicle type is type approved.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;